Activity and safety of ODM-201 in patients with progressive metastatic castration-resistant prostate cancer (ARADES): an open-label phase 1 dose-escalation and randomised phase 2 dose expansion trial
| Autor: | Fizazi, Karim, Massard, Christophe, Bono, Petri, Jones, Robert, Kataja, Vesa, James, Nicholas, Garcia, Jorge A, Protheroe, Andrew, Tammela, Teuvo L, Elliott, Tony, Mattila, Leena, Aspegren, John, Vuorela, Annamari, Langmuir, Peter, Mustonen, Mika |
|---|---|
| Zdroj: | In Lancet Oncology August 2014 15(9):975-985 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|